Skip to main content
. 2017 Jun 19;7:3831. doi: 10.1038/s41598-017-03940-1

Figure 4.

Figure 4

HepG2 cell viability in the presence of PBA or TUDCA: HepG2 cell viability was measured by MTT assay as described in ‘Materials and Methods’. Panel A: Cells were treated with different concentrations of PBA (0.5–20 mM) or with 12 µM tunicamycin for 48 h. Panel B: IC50 value for PBA as determined by using GraphPad Prism 6 software. Panel C: Cell viability in the presence of different concentrations of TUDCA (0.25–10 mM) or 12 µM tunicamycin for 48 h. Data shown are mean ± SD, (n = 3). The asterisks represent statistically significant differences (*P < 0.05, **P < 0.01). P value is calculated by t-test.